214 related articles for article (PubMed ID: 14740508)
1. Palliative treatment for advanced or metastatic osteosarcoma.
Merimsky O; Kollender Y; Inbar M; Meller I; Bickels J
Isr Med Assoc J; 2004 Jan; 6(1):34-8. PubMed ID: 14740508
[No Abstract] [Full Text] [Related]
2. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
3. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
4. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
5. Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Burgers JM
Cancer Treat Res; 1993; 62():173-5. PubMed ID: 8096730
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
[No Abstract] [Full Text] [Related]
8. [New therapeutic options for mesothelioma].
Ruffié P
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S15-8. PubMed ID: 12538927
[No Abstract] [Full Text] [Related]
9. The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
Craft AW; Burgers JM
Cancer Treat Res; 1993; 62():279-86. PubMed ID: 8096743
[No Abstract] [Full Text] [Related]
10. Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Zak D; Styler MJ; Rosenbluth JZ; Brodsky I
Clin Adv Hematol Oncol; 2005 Apr; 3(4):297-9; discussion 300-2. PubMed ID: 16167002
[No Abstract] [Full Text] [Related]
11. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
Souquet PJ; Gérinière L
Rev Pneumol Clin; 2000 Nov; 56(5):315-9. PubMed ID: 11139761
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Rudd RM; Gower NH; Spiro SG; Eisen TG; Harper PG; Littler JA; Hatton M; Johnson PW; Martin WM; Rankin EM; James LE; Gregory WM; Qian W; Lee SM
J Clin Oncol; 2005 Jan; 23(1):142-53. PubMed ID: 15625369
[TBL] [Abstract][Full Text] [Related]
14. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
[TBL] [Abstract][Full Text] [Related]
15. Primary treatment of pelvic osteosarcoma. Report of five cases.
Estrada-Aguilar J; Greenberg H; Walling A; Schroer K; Black T; Morse S; Hvizdala E
Cancer; 1992 Mar; 69(5):1137-45. PubMed ID: 1371232
[TBL] [Abstract][Full Text] [Related]
16. Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.
Pintoffl J; Meisinger I; Mayer F; Horger M; von Weyhern C; Kanz L; Hartmann JT
Anticancer Drugs; 2009 Jan; 20(1):73-4. PubMed ID: 19343003
[No Abstract] [Full Text] [Related]
17. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma.
Palmerini E; Ferrari S; Bertoni F; Bacci G
Clin Orthop Relat Res; 2007 Sep; 462():255; author reply 255-6. PubMed ID: 17804967
[No Abstract] [Full Text] [Related]
19. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Altundag K; Aksoy S; Gullu I; Altundag O; Ozyar E; Yalcin S; Cengiz M; Akyol F
Med Oncol; 2004; 21(3):211-5. PubMed ID: 15456947
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
